According to the American Cancer Society, smoking damages most organs in the human body and is linked to at least 10 different cancers. Smoking accounts for nearly 30 percent of all cancer deaths. Yet one in four Americans still lights up. So how many days are you taking away from the longevity of your life every time you light up.

According to studies on smokers, if you smoke 1 pack of cigarettes a day for 10 years you lose 2 years of your life. If you smoke 2 packs in 10 years time you lose 4 years. If you have smoked one pack of cigarettes a day for 20 years you lose 4 years off of your life and if you smoke 2 packs a day in 20 years you lose 9 years off of your life.

You are just as much at risk if you are breathing second hand smoke. Make the commitment today to quit smoking and live longer or help someone you love give up the habit that strips away years of their lives.

My gut hasn't always guided me through life's most difficult decisions and dilemmas. It wasn't until I felt a lump in my breast more than two years ago that my gut kicked into gear and told me something very important.

"It's cancer," my insides told me one week before the surgeon who did my biopsy called.

"It's cancer," the surgeon said. I didn't tell him, but I thought it: "I know."

I also knew prior to surgery that my cancer had not spread to my lymph nodes. My gut told me this too. It also told me the chemotherapy drug Taxol was not right for me -- since my cancer had not spread -- despite the urging of one oncologist that I accept this treatment. I would have gone on gut instinct alone in my rejection of this medication but another doctor weighed in and agreed with my gut, so I had solid backing on this decision.

Many have dismissed hunches like these and have written off those who believe in them as screwballs, says writer Chip Brown in the March 2007 issue of The Oprah Magazine. But as Brown shares after peering into the world of gut instinct, there are 100 million nerve cells in the gut. They run on autopilot, regulate digestion, play a critical role in the body's immune system, and control mood-altering neurotransmitters identical to those in the brain.

The gut is essentially a second brain. It was a "gut feeling" that led Fred Smith, founder of Federal Express, to begin exploring the possibilities of overnight delivery and Howard Schultz, founder of Starbucks, to begin mass marketing coffee. Wall Street professionals make millions on their gut feelings, sportscasters make startling predictions based on gut guidance, and entrepreneurs launch thriving businesses because of the inklings that rumble in their tummies.

You may or may not be a gut thinker yourself. But I've stumbled upon a gut exercise -- thanks to psychotherapist Nancy Napier --and I'd like for you to consider it the next time you find yourself stuck at a crossroads, unsure of where to turn. You never know, the direction you seek may be swirling around in your midsection, just waiting for a call to action.

Think about this:

You are wavering between two choices. Find yourself a quiet, serene place where there will be no disruptions. Now sit down. Take a moment to settle and focus on the issue you want to explore. Then choose one side. Think about this side and notice what happens in your gut. Do you feel a tightening and gripping or a softening and warming? Are the sensations pleasant or uncomfortable? Notice your thoughts. Are they positive or negative? Give yourself some time to feel your gut and your mind responding.

Now shift to the other side. Think about the previous questions, and try to chart what your body gut is saying.

While you may not get a gut answer at first, if you come back with the question several times, you'll likely hear just what your gut wants you to know.

For those of you living for the moment, you are about to lose 60 whole minutes come Sunday when Daylight-saving time strikes once again.

This may throw you off a bit if you are one to maximize every second, minute, and hour you are afforded in this tenuous life. And while I can't offer you any secrets for recapturing this lost time, I can share some thoughts, compliments of professional organizer Linda Richards of Organize and More, on how you might compensate for Sunday's lost hour.

Think about this:

• Go to bed 15 minutes earlier and get up 15 minutes earlier starting a few days before the time change.
• Move any important meetings to later in the week so you body isn't as tired.
• Snack on healthy foods such as fruits and nuts to replenish energy.
• Shorten your to-do list to your top three to five priorities.
• Print out a copy of your calendar and appointments for March and make sure your computer has a patch to handle the earlier time change this year.
  

The second issue of the magazine Beyond: Live & Thrive After Breast Cancer will hit newsstands March 20.

The magazine, one of many targeting individuals with manageable conditions and diseases, such as allergies, heart disease, diabetes, and rheumatoid arthritis, stands out as an upbeat, positive, feel-good package of information and inspiration.

University of Mississippi journalism professor Samir Husni says magazines of this sort that succeed are the ones offering up a good dose of chicken soup for the soul. This is definitely a magazine good for the soul.

Beyond editor Martha Miller Johnson calls the magazine a purveyor of hope and information, a source of reliable facts, figures, and features for the growing community of survivors living with breast cancer. Beyond is for "the women who has been through her initial treatment and now sees her life through a different prism," says Johnson.

"Her body's changed, her skin's changed. To her, it's not a death sentence; it's a condition she just has to live with. More and more women are living with breast cancer."

The soon-to-be-released publication spotlights breast cancer survivor Deanna Favre with husband Brett Favre and includes stories about breast cancer and black women, chemotherapy and weight gain, and the most important questions to ask your doctor.

Why pick up a copy of Beyond's Spring/Summer issue this March 20? Because breast cancer attacks so many aspects of our well-being, says one survivor of the disease.

"It's your identity, it's your sexuality, it's your womanhood. Fertility. For many of us, it throws us into menopause early," she says. "Every aspect of your emotional and psychological well-being is impacted by cancer and the treatment. So that kind of puts it in its own category, I think. So you combine that with the fact that there are so many women going through it, and I think you do have a market there for something like this."

I couldn't have said it better.

We all know breast cancer strikes women -- a lot of women -- but about 1,700 men also develop the disease each year in the United States. And while their risk of diagnosis is much more hopeful than the reality facing women, men with breast cancer face their own version of a not-so-rosy reality.

According to researchers at the University of California, Irvine, men treated for breast cancer face a very real chance of getting cancer again. Their study found that 11.5 percent of men with breast cancer develop second primary cancers -- mostly in the breast, stomach, and skin -- within two months following initial treatment.

"Even more disturbing, we found that men with breast cancer are diagnosed with later-stage disease and that patients with onset of the disease at a young age are even more likely to develop a second cancer," said Hoda Anton-Culver, chief of epidemiology in the UCI School of Medicine.

In light of these findings, researchers recommend men with breast cancer be closely monitored for a second onset of cancer.

In 1971, when it was evident cancer deaths were rising, President Nixon and Congress declared a war on cancer. Finally, after 35 years, it seems we are winning the war.

Experts say the absolute decline in cancer deaths is quite amazing -- because our population is both growing and aging, both of which could contribute to an increased cancer death rate. But prevention, early detection, and early treatment are working wonders and are saving lives for three of the most common cancers -- breast cancer, prostate cancer, and colorectal cancer. More and more men are also surviving lung cancer due to cessation of smoking more than 20 years ago. The female lung cancer death rate is not declining, however, due to continued high rates of smoking.

The highest drop in deaths among the major cancers was for colorectal cancer -- thanks to effective screening methods. Deaths dropped by 1,110 for men and 1,094 for women.

According to an American Cancer Society review of U.S. death certificates, cancer deaths declined by 369 between the years 2002 and 2003. Between 2003 to 2004, the decrease was 3,014 -- more than eight times greater.

Experts predict cancer deaths will continue to decline over the years -- although some expect the obesity epidemic, which increases risk for all cancers, to pop the cancer death rate back up in the long run.

Dr. Len Lichtenfeld, MD, is the deputy chief medical officer for the American Cancer Society. He is also a blogger and authors his very own blog -- called Dr. Len's Cancer Blog.

Dr. Len writes on his blog about all sorts of topics related to cancer. He shares his opinion on the recent drop in breast cancer cases (December 15, 2006), he promotes the Great American Smokeout (November 14, 2006), he sounds off on lung cancer screenings (October 25, 2006), and he urges parents to always slather sunscreen on their children (October 5, 2006). He has so much more to say -- and his blog is a great stop for those wishing for more information on hot cancer topics.

As this year comes to a close, Dr. Len offers a review of what he believes were the hottest cancer topics of 2006.

Dr. Len reflects in his blog about decreased cancer death rates that represent real progress in the fight against cancer. He calls the HPV vaccine a breakthrough and he recaps the STAR trial -- a comparison of raloxifene to tamoxifen to reduce the risk of recurrent breast cancer in post-menopausal women -- with emphasis on how raloxifene proved just as effective as tamoxifen, but with a better safety profile. He calls new targeted therapies a dream -- with a hefty price tag -- sure to garner debate and discussion in 2007.

Dr. Len reviews the Surgeon General's report on second-hand smoke -- it's harmful to non-smokers, the report says -- and he marvels at the capability of science to approach an understanding of what makes a cancer cell a cancer cell. He also remarks on how remarkable it is that chronic myelogenous leukemia is in fact chronic and no longer fatal, thanks to the drug Gleevec.

Of course, there is ample attention given to the declining incidence of breast cancer, reportedly due to less women using hormone replacement therapy, and the risks weighing on those who are overweight and obese, and survivors and supporters who gathered for Celebration on the Hill -- the site of one incredible American Cancer Society event.

Dr. Len closes his review of 2006 with recognition of three celebrities who lost their lives this year to cancer -- Dana Reeve, Ann Richards, and Ed Bradley. And while he recognizes there are other lives and other stories that deserve mention, there is simply not enough time or space for him to do justice to every noteworthy item.

"What we have seen over the past year is an incredible leap forward in cancer research, diagnosis and treatment, and I suspect there are going to be even more exciting developments in the coming year," says Dr. Len who looks forward to 2007 -- a year that is sure to deliver more hope and more progress in the fight against cancer.

A new study shows that getting a second opinion when diagnosed with breast cancer can make a big difference for the patient. The researchers at the University of Michigan in Ann Arbor reported that more than half of breast cancer patients that sought a second opinion got a different recommendation for treatment. The second opinions were from a multidisciplinary tumor board. The board includes many specialists who treat breast cancer. The tumor board usually consists of surgeons, radiation oncologists, medical oncologists and pathologists working together to find the most optimal treatment for the patient.

Sometimes first treatment recommendations do not consider new techniques. The tumor board can help patients make those difficult treatment decisions they are faced with when diagnosed. Most of the time the patient will see the specialists individually. This can be fine and is what I encountered when diagnosed, however, more heads working together seem to be a better option especially if you are a breast cancer patient with a case that falls in one of those gray areas where the need for radiation or chemotherapy is questionable.

I think this approach is becoming a more popular way to find the best treatment option for breast cancer patients. If a tumor board is not something that you can utilize it is still in the patient's best interest to seek out a second opinion when they can to make sure they are hearing what all of their options are for better decision making.

I started my breast cancer treatment under the care of one oncologist. And then in a search for more warmth and compassion, I landed in a new relationship with a new oncologist. He offered me just what I was seeking. Plus something I didn't expect.

My new oncologist offered me a new treatment plan -- a new course of action that better suited my specific disease.

U.S. researchers reported yesterday that breast cancer patients were urged to change their treatment plan more than half the time when they received a second opinion from a multidisciplinary panel of surgeons, radiation oncologists, medical oncologists, radiologists, and pathologists.

Researchers at the University of Michigan Comprehensive Cancer Center believe second-opinion changes are a result of different interpretations of breast imaging and pathology results, consideration of new techniques and treatments, discovery of undiagnosed second cancers, and emerging medical research.

It wasn't a formal multidisciplinary team that delivered me a new, better opinion for my own cancer care. It was one man, who merged instinct and science and then consulted a well-know oncologist friend who agreed with the approach I ended up following.

I am thankful for everything I gained from my second opinion -- the warmth, the compassion, the treatment plan that has served me well for two years.

Celebrex (celecoxib) does not seem to show any benefit in patients receiving second line chemotherapy for lung cancer. Second line chemotherapy refers to treatment given when the initial treatment does not work or stops working.

According to the results of a phase II clinical trial published in the Journal of Clinical Oncology, the effectiveness of Celebrex is not seen when added to chemotherapy for patients with non-small cell lung cancer (NSCLC). Researches conducted the trial among 133 patients with stage IIIB or Stage IV NSCLC. Aside from pain, the addition of Celebrex did not improve patient symptoms or outcomes. One year survival was 24 percent among patients treated with Celebrex and chemotherapy and 36 percent among patients treated with chemotherapy alone.

Celebrex is a non-steroidal anti-inflammatory agent that inhibits the COX-2 enzyme, which plays a role in inflammation. There has been some evidence that COX-2 inhibitors may increase response to chemotherapy. Further research needs to be conducted since it is still possible that specific subsets of patients with NSCLC may benefit from COX-2 inhibitors.

The magazine Beyond: Live and Thrive After Breast Cancer made its public debut on September 19 when it arrived on the shelves of bookstores and grocery stores across the United States. And the magazine -- created to help breast cancer survivors nurture their physical and emotional health -- has caused quite a stir already.

Readers of a previous Cancer Blog post introducing the magazine say they can't get enough it and can't wait for the next issue. Contributing Editor Martha Miller Johnson says it's been a crazy month for the magazine team. She reports that the magazine is selling incredibly well, that she is receiving the most amazing e-mails from a wonderful group of women. The Des Moines Register and Connecticut Post both have done big stories on the magazine and in the midst of the flurry of success, work has already begun on the next and second issue that will hit newsstands on March 20, 2007.

Beyond is published by Meredith Special Interest Media twice per year in Fall/Winter and Spring/Summer editions. Currently, subscriptions are not available, but the magazine is available all across America and can also be purchased on-line.

It's no surprise this magazine has caught the attention of people everywhere. It's a timely, colorful, glossy breast cancer handbook. It's chock full of candid stories, recent research, and helpful hints. It's a breast cancer community that is inspiring, hopeful, and completely comforting.

I was in the emergency room the other night with my three-year-old who was experiencing a mysterious leg pain that resulted from a bad case of strep throat. It wasn't serious enough to warrant swift movement from the waiting room to an actual room and we sat in a holding pattern with a crowd of other patients, some of whom were still waiting after Danny had been treated and released. I was told patients are served in the order in which they arrive but also according to the seriousness of their complaints -- which takes me back to the night I was in the ER with a fever, headache, sore throat, and sore gums. The night I was given a mask and was immediately escorted from the waiting room to a private room where doctors and nurses treated me for neutropenia -- a condition caused by chemotherapy and marked by a drop in neutrophil levels, a condition that puts chemotherapy patients at great risk for infection. This was the second time I went to the hospital for neutropenia. Both times I was admitted and treated for five days.

And so sitting in the ER reminded me about how serious chemotherapy side effects can be. And it makes me want to caution all chemotherapy patients to never dismiss the signs that the body is suffering -- to never tough it out with the hope that a good night's sleep or a few days rest will straighten everything out. Because it may not -- and the end result may be tragic.

All chemotherapy patients should be briefed by their medical teams about when to call for medical assistance. For me, a temperature of 100.4 was the magic call-for-help signal. And twice, I called for help -- once in the middle of the night. But any symptoms , and definitely a combination of symptoms, are cause enough for a simple phone call. So don't delay. Don't excuse warning signs that your body is struggling. Don't second-guess your decision to notify a medical professional about your symptoms. Just call. It could save your life.

I like to read. I just don't find much time to do it -- with two kids, two jobs, an unpredictable exercise schedule, endless medical appointments, and all the other craziness that accompanies life. I would like to find more time for books -- books a bit more complex than the one I found time to read at bedtime tonight about a frog and a toad who spend their days flying kites and enjoying picnics together. I would like to read books that capture relationships and life experiences and a bit of mystery too.

The last book I read -- The Shop on Blossom Street -- is the kind of book I like. It is easy to read and captivating and inspiring and comforting. It is the kind of book I want to keep reading -- long after I have to put it down to tend to distractions. Perhaps it's the thread of cancer woven into the storyline of this book that kept me wanting more.

The Shop on Blossom Street -- by Debbie Macomber -- follows four women who are all seeking change in their lives. The lead character opens a yarn shop, years after a cancer diagnosis and with the intention of moving forward despite an uncertain future. She hosts knitting classes and forms relationships with three other women in search of brighter days.

Character Lydia Hoffman -- the cancer survivor -- overcomes obstacles and challenges and even another cancer scare. She finds friendship and love and all sorts of unexpected discoveries. She even graces the pages of a second book -- A Good Yarn -- that follows her continued life journeys.

I have the book A Good Yarn. It's on my bookshelf. And I can't wait to read it. I just can't find the time.

We recently posted Elephant Man drug trial victim showing signs of cancer, about a horrific ordeal involving six healthy young men who volunteered at Northwick Park Hospital, in London as participants in a clinical trial for a drug called TGN1412, designed to treat leukemia, autoimmune and inflammatory diseases.

According to the men, they were told by doctors there would be no serious short-term or long-term side effects from participating in the drug trial. That wasn't the case. The participants were misled regarding the safety of the experimental drug -- everything went terribly wrong -- and one of the six men has now been told he is showing signs of cancer.

Another egregious event has occurred on the other side of the pond, according to news of an allegation made by a woman who claims she was used as an experimental cancer drug guinea pig without consent.

The story began last year when Trelene Cave was diagnosed with ovarian cancer. Treated at Epsom General Hospital and the Royal Marsden Hospital in Sutton, she was later sent to St George's Hospital for a second opinion before undergoing an operation. The trouble begins when St George's Hospital doctors allegedly treated Cave with Scotroc4, an experimental cancer drug, without her informed consent. She developed a blood clot and almost died.

Cave states in the news report that, "I trusted them totally. Nobody discussed it with me. I just can't understand it."

St George's Healthcare Trust has apologized to her and her husband Norman for the incident. An investigation has been called for into whether St George's Hospital doctors side-stepped ethical guidelines in treating Cave without her knowledge.

Thanks to Joel Arellano of Autoblog for this story tip!

The White Rock city council has asked the city's social and economic development committees to study a proposal that would ban the sale of all tobacco products in their small idyllic seaside town, and report back on its feasibility.

Councilman Matt Todd, who proposed the ban, said "I got tons of calls and e-mails from people who are asthmatics or just allergic to cigarettes or had family members die from smoke, or were cancer researchers or worked in cancer wards. Clearly this is a public dialogue that people are wanting to have."

According to news reporting, if the city council approves the ban, White Rock will become the first city in Canada to ban outright the sale of cigarettes and other tobacco products. White Rock is located on the southern coast of British Columbia, Canada.